- Report
- February 2023
- 30 Pages
Japan
From €2464EUR$2,750USD£2,111GBP
- Report
- February 2023
- 30 Pages
Global
From €2464EUR$2,750USD£2,111GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2464EUR$2,750USD£2,111GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2464EUR$2,750USD£2,111GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2464EUR$2,750USD£2,111GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2464EUR$2,750USD£2,111GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2499EUR$2,789USD£2,141GBP
- Report
- June 2024
- 200 Pages
Global
From €7123EUR$7,950USD£6,102GBP
- Report
- June 2024
- 200 Pages
Global
From €7123EUR$7,950USD£6,102GBP
- Report
- February 2022
- 269 Pages
Global
From €8512EUR$9,500USD£7,291GBP
- Report
- January 2022
- 200 Pages
Global
From €6720EUR$7,500USD£5,756GBP
- Report
- May 2024
- 138 Pages
Global
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- May 2024
- 140 Pages
Global
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- May 2024
- 136 Pages
Global
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- May 2024
- 175 Pages
Global
From €2240EUR$2,500USD£1,919GBP
- Report
- April 2024
- 172 Pages
Global
From €2240EUR$2,500USD£1,919GBP
- Report
- February 2026
- 137 Pages
Australia
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- March 2025
- 114 Pages
Global
From €16124EUR$17,995USD£13,811GBP
- Report
- April 2025
- 20 Pages
Global
From €16124EUR$17,995USD£13,811GBP
- Report
- December 2024
- 34 Pages
Global
From €3580EUR$3,995USD£3,066GBP

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more